Related references
Note: Only part of the references are listed.Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
Emi J. Yoshida et al.
CANCER (2020)
A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx
Samuel Swisher-McClure et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).
Robert L. Ferris et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
De-intensification of therapy in human papillomavirus associated oropharyngeal cancer: A systematic review of prospective trials
Roshal R. Patel et al.
ORAL ONCOLOGY (2020)
Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV plus oropharyngeal carcinoma patients: The Quarterback trial
K. Misiukiewicz et al.
ORAL ONCOLOGY (2019)
Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus?Associated Oropharyngeal Squamous Cell Carcinoma
Bhishamjit S. Chera et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison et al.
LANCET (2019)
Head and Neck Cancers-Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual
William M. Lydiatt et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review
Primoz Strojan et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study
Brian O'Sullivan et al.
LANCET ONCOLOGY (2016)
Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Multicenter Study in Japan
Takanori Hama et al.
ONCOLOGY (2014)
Comparative Prognostic Value of HPV16 E6 mRNA Compared With In Situ Hybridization for Human Oropharyngeal Squamous Carcinoma
Wei Shi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Case-control study of human papillomavirus and oropharyngeal cancer
Gypsyamber D'Souza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Share Paper
